A Novel Mutation of the ADAR1 Gene in a Chinese Family with Dyschromatosis Symmetrica Hereditaria and Literature Review
Hongping Ge,Na Zhang,Xinru Chen,Meiyan Wang,Tianhui Ye
DOI: https://doi.org/10.2147/ccid.s475880
2024-11-30
Clinical Cosmetic and Investigational Dermatology
Abstract:Hongping Ge, 1, 2 Na Zhang, 1 Xinru Chen, 1, 3 Meiyan Wang, 1 Tianhui Ye 1, 3 1 Department of Dermatology, Jinhua Municipal Central Hospital (Affiliated Jinhua Hospital, Zhejiang University School of Medicine), Jinhua City, Zhejiang Province, People's Republic of China; 2 Department of Dermatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang; 3 Department of Dermatology, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Correspondence: Na Zhang, Email Background: Dyschromatosis symmetrica hereditaria (DSH) is a rare genetic skin condition characterized by pigmented macules on the hands, feet, and sometimes the face. The ADAR1 gene is responsible for this autosomal dominant disorder. Objective: This study aimed to analyze a three-generation Chinese family with DSH, identify a novel ADAR1 gene mutation, and conduct a comprehensive literature review of Chinese DSH families to enhance understanding of the genetic basis and clinical manifestations. Methods: Clinical reports, mutation analysis, and literature reviews were conducted. A literature search was performed using PubMed. Results: A novel heterozygous nonsense mutation, c.763C>T (p.Q255X), in the ADAR1 gene was identified in the proband and five other affected individuals. Literature review findings revealed prevalent mutation sites and clinical data in Chinese DSH families over the past two decades. Limitations: The number of databases searched was limited, and the treatment outcomes for patients were not deemed satisfactory. Conclusion: This study provides valuable insights into the genetic basis and clinical features of DSH in Chinese families, shedding light on prevalent mutation sites and clinical data. Further research is needed to explore the relationship between gene mutations and clinical phenotypes and advance therapeutic interventions for DSH. Keywords: dyschromatosis symmetrica hereditaria, ADAR1 gene, mutation analysis Dyschromatosis symmetrica hereditaria (DSH: OMIM #127400, also called "reticulate acropigmentation of Dohi"), which is clinically characterized by a mixture of hyperpigmented and hypopigmented macules distributed on the dorsal aspects of their hands and feet. Some patients with DSH have freckle-like pigmented macules on the face. It is a rare autosomal dominant pigmentary genodermatosis with high penetrance. The skin lesions of this disease start in infancy or early childhood, cease spreading before adolescence, and persist throughout life. According to current literature, DSH is predominantly reported in Japan and China. 1 In 2003, Zhang et al 2 conducted gene detection on two Chinese DSH families and first identified the pathogenic gene for DSH located at chromosome 1q11-1q21. The gene responsible for DSH, known as the double-stranded RNA-specific adenosine deaminase (DSRAD) gene, has been located on chromosome 1q21.3 and comprises 15 exons. This gene is also referred to as the adenosine deaminase acting on RNA 1 (ADAR1) gene. 3 All procedures involving human participants were conducted in accordance with the ethical standards of the Ethics Committee of the Jinhua Municipal Central Hospital and the Helsinki Declaration. All patients, their normal family members, and 100 ethnically matched controls were informed about the purpose of the study and provided written consent prior to recruitment and sampling. Informed written consent for minors has been obtained from their legal guardians. In this study, we investigated a three-generation Chinese family with DSH (Figure 1a). All affected individuals had typical hyperpigmented and hypopigmented macules on the dorsal aspects of hands and feet. These skin lesions are irregular in shape and size, but they are asymptomatic. The cutaneous lesions of these patients are consistent with the typical clinical manifestations of DSH. The proband, individual III1, is a 31-year-old man. He developed an asymptomatic mixture of hyperpigmented and hypopigmented macules on dorsal aspects of his hands and feet at the age of 5. (Figure 1b and c) Besides the proband, there are five other affected individuals in the family. The other affected family members all have varying degrees of hyperpigmented and hypopigmented macules located on the dorsum of the hands and feet. Onset of symptoms occurred before the age of 6 for all affected individuals. It is worth noting that the proband in the family had the most severe skin lesions, which prompted a visit to our dermatology department for comprehensive genetic testing. Additionally, according to the patient and their fa -Abstract Truncated-
dermatology